Press Releases
What are the trends shaping biopharma in 2025? ADC Process Development Director Song Young Kim shares his insights on overcoming ADC manufacturing and supply chain challenges.
"Since ADCs consist of an antibody, a cytotoxic payload, and a chemical linker, companies tend to rely on different vendors for each component, complicating the supply chain.
Biotech and pharmaceutical companies are overcoming these challenges by partnering with CDMOs that have specialized facilities for ADC manufacturing and the analytical capabilities necessary to support every step of the journey."
Read more in the latest Pharma Manufacturing article.
What are the trends shaping biopharma in 2025? ADC Process Development Director Song Young Kim shares his insights on overcoming ADC manufacturing and supply chain challenges.
"Since ADCs consist of an antibody, a cytotoxic payload, and a chemical linker, companies tend to rely on different vendors for each component, complicating the supply chain.
Biotech and pharmaceutical companies are overcoming these challenges by partnering with CDMOs that have specialized facilities for ADC manufacturing and the analytical capabilities necessary to support every step of the journey."
Read more in the latest Pharma Manufacturing article.